The Kingsley Clinic

Nitric Oxide Measurement: Essential Test for Asthma & Inflammation

Introduction

Measuring nitric oxide levels in exhaled air is an innovative diagnostic approach that provides valuable insights into lung health. Known as the exhaled nitric oxide test or FeNO test (fractional exhaled nitric oxide), this procedure evaluates the concentration of nitric oxide in your breath. Nitric oxide, a naturally occurring gas in the body, serves as a key indicator of airway inflammation—a hallmark of conditions such as asthma.

First introduced in the late 1990s, this non-invasive test has become an essential tool for diagnosing and managing respiratory conditions. It is particularly beneficial for individuals with asthma, as it helps healthcare providers assess airway inflammation and tailor treatment plans to meet specific needs. In this article, we will explore the details of nitric oxide measurement in exhaled air, its importance in healthcare, and its role as a critical resource for managing respiratory health.

Whether you are considering an asthma diagnostic test or looking for effective ways to monitor airway inflammation, understanding this test can empower you to take charge of your health. Let’s dive into how it works and why it is so significant.

What is a Nitric Oxide Measurement in Exhaled Air?

A nitric oxide measurement in exhaled air, or FeNO test, is a simple, non-invasive procedure designed to assess nitric oxide levels in your breath. Nitric oxide, produced naturally by cells in your body, provides important clues about respiratory health. Elevated levels of exhaled nitric oxide often signal airway inflammation, a key feature of asthma and other respiratory conditions.

The test itself is straightforward and completely painless. During the procedure, you will be asked to exhale slowly and steadily into a handheld device, which measures the concentration of nitric oxide in your breath and delivers results almost instantly. The entire process typically takes less than 10 minutes, making it a quick and convenient option for patients of all ages, including children.

Healthcare providers use the FeNO test to gain a deeper understanding of airway inflammation. Unlike traditional lung function tests, which measure airflow and lung capacity, this test focuses specifically on inflammation at the molecular level. As a result, it serves as a valuable complement to other diagnostic tools, particularly for individuals with suspected or confirmed asthma.

For patients, the FeNO test offers a combination of simplicity and precision. It eliminates the need for invasive procedures, such as blood tests or imaging studies, relying solely on your breath to provide critical diagnostic information. This makes it a safe and comfortable experience while delivering highly accurate results.

In addition to aiding diagnosis, the FeNO test is also a powerful tool for monitoring treatment effectiveness. By tracking changes in nitric oxide levels over time, healthcare providers can determine whether your current treatment plan is successfully reducing airway inflammation. This information helps guide adjustments to medication dosages or other aspects of your care plan, ensuring optimal management of your condition.

Why is a Nitric Oxide Measurement in Exhaled Air Important?

The importance of nitric oxide measurement in exhaled air lies in its ability to provide precise, actionable insights into airway inflammation. For individuals with asthma, this test is particularly valuable, as it helps confirm the diagnosis and monitor the condition over time. Asthma, a chronic respiratory disease, is characterized by inflammation and narrowing of the airways, leading to symptoms such as wheezing, coughing, and shortness of breath. Effectively managing this inflammation is essential for successful treatment.

Unlike other diagnostic methods, such as spirometry or peak flow tests, the FeNO test directly measures a biomarker of inflammation. This allows healthcare providers to detect airway inflammation even before symptoms become severe. For patients, this means earlier intervention and a greater chance of preventing asthma attacks or complications.

Another significant advantage of the FeNO test is its role in personalized medicine. By analyzing your specific nitric oxide levels, healthcare providers can customize treatment plans to suit your unique needs. For example, if nitric oxide levels remain elevated despite treatment, adjustments to medication or additional therapies may be necessary to achieve better control of your condition.

While the FeNO test is primarily used for asthma management, ongoing research is exploring its potential applications in other respiratory conditions, such as chronic obstructive pulmonary disease (COPD) and allergic rhinitis. These studies suggest that the test could become a valuable diagnostic tool for a broader range of patients in the future.

For those searching for an “exhaled nitric oxide test near me,” this diagnostic tool is widely available at primary care offices, pulmonary clinics, and specialized asthma centers. Its accessibility and effectiveness have made it a cornerstone of modern respiratory care.

In summary, the FeNO test is more than just a diagnostic tool—it provides a comprehensive view of airway health. By measuring nitric oxide biomarkers in your breath, it delivers critical information that enhances diagnosis, guides treatment, and ultimately improves quality of life.

What Does a Nitric Oxide Measurement in Exhaled Air Diagnose?

The measurement of nitric oxide (NO) levels in exhaled air, commonly referred to as a FeNO test (fractional exhaled nitric oxide test), is a highly effective diagnostic tool for evaluating airway inflammation. This non-invasive test offers insights into a variety of respiratory and systemic conditions by detecting elevated or reduced nitric oxide levels in the breath. To ensure its diagnostic accuracy, two key metrics are used: the positive predictive value (PPV), which indicates how often a positive result correctly identifies a condition, and the negative predictive value (NPV), which reflects how often a negative result correctly rules out a condition. These metrics ensure the FeNO test is both reliable and clinically meaningful.

Below, we explore how nitric oxide measurement in exhaled air aids in diagnosing specific conditions, with a focus on its role in identifying airway inflammation and related diseases.

Asthma

Asthma is a chronic respiratory condition characterized by airway inflammation, bronchial hyperresponsiveness, and intermittent airflow obstruction. Symptoms may include wheezing, shortness of breath, chest tightness, and coughing, which can vary in severity and frequency. Diagnosing asthma typically involves a combination of clinical evaluation, lung function tests, and biomarkers such as exhaled nitric oxide levels.

Asthma and Nitric Oxide Measurement

Diagnosing asthma typically involves a combination of clinical history, lung function tests, and biomarkers such as exhaled nitric oxide levels. The exhaled nitric oxide test (FeNO test) is particularly effective in identifying eosinophilic airway inflammation, a hallmark of asthma. Elevated nitric oxide levels in the breath are strongly associated with this type of inflammation.

Studies show that FeNO levels above 50 parts per billion (ppb) in adults and 35 ppb in children have a positive predictive value (PPV) of approximately 80% for diagnosing asthma. Conversely, low FeNO levels have a negative predictive value (NPV) of about 85%, making the test a reliable method for ruling out asthma in individuals with normal results. Additionally, the FeNO test is a valuable tool for monitoring asthma management and predicting how well a patient might respond to corticosteroid therapy.

Chronic Obstructive Pulmonary Disease (COPD)

Chronic obstructive pulmonary disease (COPD) is a progressive lung condition that includes emphysema and chronic bronchitis. It is characterized by persistent symptoms such as chronic cough, sputum production, and shortness of breath, which result from airflow limitation and inflammation.

While COPD is primarily associated with neutrophilic inflammation, some patients may also exhibit eosinophilic inflammation, which can be detected through elevated nitric oxide levels. The FeNO test is useful in distinguishing COPD from asthma, as COPD patients generally have lower FeNO levels compared to those with asthma. However, in cases of asthma-COPD overlap syndrome, FeNO levels may be moderately elevated. The test has a PPV of around 70% for identifying eosinophilic inflammation in COPD and an NPV of approximately 75% for ruling it out.

Allergic Rhinitis and Exhaled Nitric Oxide

Allergic rhinitis, commonly known as hay fever, is an allergic condition affecting the nasal passages. It causes symptoms such as sneezing, nasal congestion, a runny nose, and itchy eyes. This condition often coexists with other allergic disorders, including asthma.

In patients with allergic rhinitis, measuring nitric oxide levels in exhaled air can reveal elevated levels due to underlying airway inflammation. The FeNO test is particularly useful for detecting subclinical inflammation in the lower airways, even in the absence of obvious asthma symptoms. This early detection is crucial, as individuals with allergic rhinitis and elevated FeNO levels are at a higher risk of developing asthma. The PPV of FeNO testing for identifying airway inflammation in allergic rhinitis is approximately 65%, while the NPV is about 80% for ruling it out.

Cystic Fibrosis and Nitric Oxide Levels

Cystic fibrosis (CF) is a genetic disorder that affects the lungs and digestive system, leading to thick mucus buildup, chronic respiratory infections, and airway obstruction.

Interestingly, patients with cystic fibrosis often exhibit lower-than-normal nitric oxide levels in their breath, likely due to impaired nitric oxide production in the airways. Although the FeNO test is not a primary diagnostic tool for CF, it provides valuable insights into the nature of airway inflammation. The NPV of FeNO testing for ruling out eosinophilic inflammation in CF is high, at approximately 85%, making it a helpful adjunct in assessing airway health.

Eosinophilic Bronchitis and the FeNO Test

Eosinophilic bronchitis is a condition characterized by chronic cough and airway inflammation without the airflow obstruction typically seen in asthma. It is caused by an increase in eosinophils, a type of white blood cell, in the airways.

The FeNO test is highly effective in diagnosing eosinophilic bronchitis, as elevated nitric oxide levels are strongly correlated with eosinophilic inflammation. A FeNO level above 50 ppb in adults has a PPV of 90% for diagnosing this condition. Additionally, the test is valuable for monitoring treatment effectiveness, as FeNO levels usually decrease in response to corticosteroid therapy.

Bronchial Hyperreactivity and Nitric Oxide Measurement

Bronchial hyperreactivity refers to an exaggerated airway response to various stimuli, a feature commonly observed in asthma and other respiratory conditions. Symptoms include coughing, wheezing, and shortness of breath.

Measuring nitric oxide levels in exhaled air can help identify airway inflammation associated with bronchial hyperreactivity. Elevated FeNO levels often indicate eosinophilic inflammation, which is frequently present in asthma-related hyperreactivity. The PPV of FeNO testing for detecting bronchial hyperreactivity is approximately 75%, with an NPV of 80% for ruling it out.

Respiratory Infections and Exhaled Nitric Oxide

Respiratory infections, such as viral or bacterial bronchitis, can cause temporary airway inflammation, leading to symptoms like cough, fever, and difficulty breathing.

During acute respiratory infections, nitric oxide levels in exhaled air may fluctuate. Viral infections often result in elevated FeNO levels due to increased airway inflammation, whereas bacterial infections may not significantly affect FeNO levels. The test is particularly useful for distinguishing eosinophilic inflammation from other types of airway involvement. The NPV of FeNO testing for ruling out eosinophilic inflammation during respiratory infections is approximately 70%.

Interstitial Lung Disease (ILD)

Interstitial lung disease (ILD) encompasses a group of disorders that cause scarring (fibrosis) of lung tissue, leading to symptoms such as shortness of breath and a persistent dry cough.

In ILD, nitric oxide levels in exhaled air are typically normal or only slightly elevated, as eosinophilic inflammation is not a primary feature of these conditions. However, the FeNO test can help rule out other potential causes of respiratory symptoms, such as asthma or eosinophilic bronchitis. The NPV of FeNO testing for excluding eosinophilic inflammation in ILD is approximately 85%.

Pulmonary Hypertension and Airway Inflammation

Pulmonary hypertension is a condition characterized by elevated blood pressure in the arteries of the lungs, leading to symptoms such as shortness of breath, fatigue, and chest discomfort.

Although the FeNO test is not a direct diagnostic tool for pulmonary hypertension, it can help identify coexisting airway inflammation that may contribute to respiratory symptoms. Elevated nitric oxide levels in the breath may indicate eosinophilic inflammation, prompting further evaluation. The PPV of FeNO testing for detecting airway inflammation in pulmonary hypertension is approximately 60%, with an NPV of 75%.

Sleep Apnea and Nitric Oxide Breath Testing

Sleep apnea is a sleep disorder characterized by repeated interruptions in breathing during sleep, which can lead to fatigue, loud snoring, and an increased risk of cardiovascular complications.

In patients with sleep apnea, nitric oxide levels in exhaled air may be mildly elevated due to intermittent airway inflammation. The FeNO test provides valuable insights into eosinophilic inflammation, particularly in individuals with overlapping asthma or allergic conditions. The PPV of FeNO testing for detecting airway inflammation in sleep apnea is approximately 65%.

Nitric Oxide Measurement: A Key Tool for Airway Inflammation Analysis

The FeNO test (fractional exhaled nitric oxide) provides healthcare professionals with a clearer picture of airway inflammation and its role in various respiratory and systemic conditions. This diagnostic tool enhances precision and supports personalized treatment strategies, ultimately improving outcomes for patients with complex respiratory needs.

How is a Nitric Oxide Measurement in Exhaled Air Performed?

The exhaled nitric oxide test is a quick, non-invasive procedure that measures the levels of nitric oxide in your breath. It is commonly used to evaluate airway inflammation, particularly in conditions like asthma. Here’s what you can expect during the process:

Preparation Steps for the Exhaled Nitric Oxide Test

Before the test, your healthcare provider may recommend avoiding certain activities or substances that could influence the results. These include:

  1. Refraining from eating or drinking: Avoid consuming food, beverages, or caffeine for at least an hour before the test.
  2. Avoiding exercise: Steer clear of strenuous physical activity for a few hours prior to the test.
  3. Skipping certain medications: If you take asthma or allergy medications, your provider may advise temporarily pausing them. Always follow your provider’s specific instructions.

The Testing Process for Nitric Oxide Levels in Breath

On the day of the test, you’ll be seated comfortably in a quiet setting. The process involves the following steps:

  1. Using the device: You’ll use a handheld device equipped with a mouthpiece designed to measure nitric oxide levels in your exhaled breath.
  2. Breathing instructions: Your provider will guide you to take a deep breath, filling your lungs completely, and then exhale slowly and steadily into the mouthpiece. Maintaining a consistent airflow is essential for accurate results.
  3. Monitoring the process: The device may offer visual cues or feedback to help you maintain proper technique.
  4. Repeating the test: You may need to repeat the process a few times to ensure the measurements are reliable.

The entire test typically takes less than 10 minutes. It is painless and non-invasive. Afterward, your healthcare provider will review the results with you and discuss the next steps.

Understanding Nitric Oxide Measurement in Exhaled Air Results

The results of a nitric oxide measurement in exhaled air provide valuable insights into the health of your airways. Here’s what they may reveal:

Normal Nitric Oxide Levels

Normal nitric oxide levels suggest minimal or no significant airway inflammation. This result may indicate that asthma or other respiratory conditions are well-controlled or that no underlying inflammation is present.

Elevated Nitric Oxide Levels

High nitric oxide levels often point to airway inflammation, which is commonly associated with asthma or other respiratory conditions. Elevated levels may indicate:

  1. Uncontrolled asthma: Persistent inflammation may signal the need to adjust your asthma management plan.
  2. Allergic reactions: Exposure to allergens can trigger airway inflammation, leading to higher nitric oxide levels.

Low Nitric Oxide Levels

Low nitric oxide levels, though less common, may reflect factors such as the use of medications that suppress nitric oxide production or the presence of non-inflammatory respiratory issues.

Discussing Your Results

Your healthcare provider will interpret your results in the context of your overall health and symptoms. If elevated levels are detected, additional tests—such as spirometry or allergy testing—may be recommended to confirm a diagnosis and guide treatment. Potential treatments include:

  1. Inhaled corticosteroids: These medications help reduce airway inflammation.
  2. Allergy management: Strategies such as allergen avoidance or allergy medications may be suggested if allergies are contributing to inflammation.

Be sure to ask questions and share any concerns during this discussion. Understanding your results empowers you to take an active role in managing your respiratory health.

Limitations and Risks of the Nitric Oxide Breath Test

While the nitric oxide breath test is a valuable diagnostic tool, it’s important to be aware of its limitations and potential risks. Here’s what you should know:

Limitations of the Exhaled Nitric Oxide Test

  1. Not a standalone diagnostic tool: The test is most effective when used alongside other diagnostic methods, such as spirometry or clinical evaluations. It cannot definitively diagnose asthma or other conditions on its own.
  2. Influence of external factors: Factors like recent food intake, smoking, or infections can affect nitric oxide levels, potentially leading to inaccurate results.
  3. Variability in results: Nitric oxide levels can vary between individuals and even within the same person over time. Results must be interpreted in the context of your overall health and symptoms.

Potential Risks of the Nitric Oxide Breath Test

The nitric oxide breath test is extremely safe, with no significant risks or side effects. However, some individuals may experience mild challenges, such as:

  1. Difficulty exhaling steadily: Maintaining a consistent airflow may be challenging for young children or individuals with severe respiratory conditions.
  2. Anxiety or nervousness: Some patients may feel apprehensive about performing the test, but healthcare providers are trained to offer guidance and reassurance.

Precautions and Preventive Measures

To ensure accurate results and minimize limitations, your healthcare provider will take steps such as offering clear instructions and creating a comfortable testing environment. If you experience any discomfort or have concerns, don’t hesitate to communicate with your provider.

Conclusion

Nitric oxide measurement in exhaled air is a simple, non-invasive test that provides valuable insights into airway inflammation and overall respiratory health. Whether it’s used to manage asthma or evaluate other respiratory conditions, this test plays a key role in guiding effective treatment plans. While it has some limitations, its benefits far outweigh any minor challenges.

As an online urgent care and primary care practice, we are here to help you understand your test results and take control of your respiratory health. If you’re experiencing symptoms or need further guidance, schedule a telemedicine appointment with us today.

James Kingsley
James Kingsley

Learn More
Scroll to Top